Vice President, Strategy and New Business Innovative Pharma
Wendy Mayer is Vice President, Strategy and New Business Innovative Pharma for Pfizer. Mayer joined Pfizer in 1997, and has had various roles across the commercial organization. Prior to her current role she was Connecticut State Director within Primary Care, responsible for approximately $200 million in revenue. Prior to that she developed a Quality Management System blueprint to embed quality by design principles into Pfizer’s enterprise-wide clinical trial process. Most of her tenure at Pfizer has been within the Market Analytics organization, utilizing primary and secondary market research to develop insights and guide global business strategy.
Prior to joining Pfizer, Wendy was a Senior Consultant at Deloitte & Touche Consulting. Before Deloitte, Wendy did an administrative fellowship at Northwestern Memorial Hospital in Chicago. Wendy holds a bachelor’s degree and MBA from Cornell University. She has been identified by Deloitte as a “Women to Watch” in healthcare for 2013.